SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹31 Cr | ₹30 Cr | ₹2.65 Cr | ₹0.73 Cr |
What is the latest Total Non-Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹2.65 Cr |
| Mar2019 | ₹0.73 Cr |
How is Total Non-Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 1.48 | |
| Mar2024 | ₹30 Cr | 1,037.96 | |
| Mar2020 | ₹2.65 Cr | 264.01 | |
| Mar2019 | ₹0.73 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹589.4 Cr | -1.1% | -6.2% | -31.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,102.0 Cr | -0.7% | 4.3% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,299.0 Cr | -0.6% | -2.6% | 6.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,753.0 Cr | 0.4% | 4.7% | 19.8% | Stock Analytics | |
| CIPLA | ₹121,735.0 Cr | -1.3% | -4.8% | 2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,155.0 Cr | -1.1% | -3.7% | 2.5% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -1.1% |
-6.2% |
-31.3% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses